 |
TransPharma Announces Successful Results of a Phase I Clinical Trial for Musculoskeletal Disorders
Drug Development and Delivery Jan 18, 2011 |
|
|
|
Successful results for osteoporosis drug
Israel 21C
Innovation News Service December 12, 2010 |
|
|
|
TransPharma's
self-applied
osteoporosis treatment produces positive results in
Phase I safety and tolerability trial
Drug
Delivery Insight November 5, 2010 |
| |
|
|
TransPharma
Announces Successful Completion of Phase Ia Clinical Trial of
ViaDor-GLP1 Agonist Indicated for Type II Diabetes
Drug
Delivery Technology Sept 17 2010 |
| |
|
|
RF-Microchannel-Based
Transdermal Delivery
Innovations in Pharmaceutical Technology, issue 27
January 2008. |
| |
|
|
TransPharma Receives European CE
Mark Approval for its Transdermal Drug Delivery Device
Drug Delivery Technology, 12.15. 2008 |
| |
|
|
TransPharma
Medical Announces Licensing & Agreement with Eli Lilly
Drug Delivery Technology, July/August 2008, Vol 8
No. 7 |
| |
|
|
Lilly
agrees transdermal licensing pact with TransPharma
Drug Delivery Insight, July 4, 2008 |
|
|
|
Israel's Delivery Woman
Israel 21c, June 30, 2008 |
|
|
|
TransPharma To Get $35M Up
Front In Lilly Deal
Dow Jones VentureWire, June 13, 2008 |
|
|
|
TransPharma
Gets $35M in Osteo Deal With Lilly
BioWorld Today, June 13, 2008 |
|
|
|
Eli Lilly & Co. will
pay TransPharma Medical Ltd. $35 million to license and develop its
experimental osteoporosis drug
Bloomberg, June 12, 2008 |
|
|
|
Eli Lilly & TransPharma
Medical Announce Licensing & Development Agreement
Drug Delivery Technology, June 12, 2008 |
|
|
|
Eli Lilly buys osteoporosis drug
patch for $35M
Forbes, June 12, 2008 |
|
|
|
Lilly Gains Access to TransPharma’s
Transdermal Osteoporosis Product for $35M
Genetic Engineering & Biotechnology News,
June 12, 2008 |
|
|
|
Eli Lilly buys rights to
TransPharma osteoporosis product
Globes, June 12, 2008 |
|
|
|
Advances in
Radio-Frequency Transdermal Drug Delivery
Pharmaceutical Technology April 2008, Volume 32,
Number 4 - Supplement |
|
|
|
For Earlier News |
